Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases, J Musculoskeletal Neuronal Interact, vol.7, pp.2-8, 2007. ,
Bisphosphonates: Molecular Mechanisms of Action and Effects on Bone Cells, Monocytes and Macrophages, Current Pharmaceutical Design, vol.16, issue.27, 2010. ,
DOI : 10.2174/138161210793563635
The molecular target of nitrogen containing bisphosphonates: the molecular pharmacology of FPP synthase, Curr Phram Des, 2010. ,
Assessment of Bishosphonate Activity In Vitro, Current Pharmaceutical Design, vol.16, issue.27, 2010. ,
DOI : 10.2174/138161210793563644
Therapeutic Approach of Primary Bone Tumours by Bisphosphonates, Current Pharmaceutical Design, vol.16, issue.27, 2010. ,
DOI : 10.2174/138161210793563554
URL : https://hal.archives-ouvertes.fr/inserm-00511241
Combined Therapies of Bone Disease with Bisphosphonates, Current Pharmaceutical Design, vol.16, issue.27, 2010. ,
DOI : 10.2174/138161210793563590
Prevention and Treatment of Bone Metastases, Current Pharmaceutical Design, vol.16, issue.27, 2010. ,
DOI : 10.2174/138161210793563581
Bisphosphonates in tumor immunotherapy, Curr Pharm Des, 2010. ,
Targeted Therapy Options for Treatment of Bone Metastases; Beyond Bisphosphonates, Curr Pharm Des, 2010. ,
Bisphosphonates and the Treatment of Multiple Myeloma, Curr Pharm Des, 2010. ,
A comparison between bisphosphonates and other treatments for osteoporosis, Curr Pharm Des, 2010. ,
Alternative use of bisphosphonate therapy for rheumatic disease, Curr Pharm Des, 2010. ,